WHITE PETROLEUM

N/A

Manufactured by Home Smart Products

195 FDA adverse event reports analyzed

Last updated: 2026-04-15

About WHITE PETROLEUM

WHITE PETROLEUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Home Smart Products. The most commonly reported adverse reactions for WHITE PETROLEUM include PYREXIA, PNEUMONIA, PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME, RENAL FAILURE, HYPERTENSION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for WHITE PETROLEUM.

Top Adverse Reactions

PYREXIA8 reports
PNEUMONIA7 reports
PALMAR PLANTAR ERYTHRODYSAESTHESIA SYNDROME6 reports
RENAL FAILURE6 reports
HYPERTENSION5 reports
BLOOD CREATININE INCREASED4 reports
DECREASED APPETITE4 reports
INFECTION4 reports
C REACTIVE PROTEIN INCREASED3 reports
CARDIAC FAILURE3 reports
CELLULITIS3 reports
DEATH3 reports
DRUG INEFFECTIVE3 reports
FEBRILE NEUTROPENIA3 reports
HAEMOLYTIC ANAEMIA3 reports
HEPATIC FUNCTION ABNORMAL3 reports
LIVER DISORDER3 reports
RASH3 reports
RESPIRATORY FAILURE3 reports
ABDOMINAL PAIN2 reports
ACUTE MYOCARDIAL INFARCTION2 reports
ACUTE RESPIRATORY DISTRESS SYNDROME2 reports
ANAEMIA2 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED2 reports
BRONCHITIS2 reports
CARDIAC FAILURE CONGESTIVE2 reports
CELLULITIS STAPHYLOCOCCAL2 reports
CEREBRAL HAEMORRHAGE2 reports
CHEST PAIN2 reports
CONSTIPATION2 reports
DIARRHOEA2 reports
DISEASE PROGRESSION2 reports
DISSEMINATED INTRAVASCULAR COAGULATION2 reports
DYSPNOEA2 reports
FUNGAL INFECTION2 reports
GENERALISED ERYTHEMA2 reports
HAEMOGLOBIN DECREASED2 reports
HEADACHE2 reports
HYPERSENSITIVITY2 reports
HYPOKALAEMIA2 reports
HYPOTHYROIDISM2 reports
IDIOPATHIC THROMBOCYTOPENIC PURPURA2 reports
INTERSTITIAL LUNG DISEASE2 reports
LACTIC ACIDOSIS2 reports
MALAISE2 reports
MALIGNANT NEOPLASM PROGRESSION2 reports
MULTI ORGAN FAILURE2 reports
NAUSEA2 reports
PAIN IN EXTREMITY2 reports
PLATELET COUNT DECREASED2 reports
PROTEIN TOTAL DECREASED2 reports
SEPTIC SHOCK2 reports
SKIN EROSION2 reports
STAPHYLOCOCCAL SEPSIS2 reports
URINARY TRACT INFECTION2 reports
WHITE BLOOD CELL COUNT INCREASED2 reports
ABDOMINAL DISTENSION1 reports
ACANTHOSIS1 reports
ACUTE GRAFT VERSUS HOST DISEASE1 reports
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER1 reports
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN1 reports
ADRENAL INSUFFICIENCY1 reports
ADVERSE EVENT1 reports
AMYLASE INCREASED1 reports
ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE1 reports
APPENDICITIS1 reports
ARTHRALGIA1 reports
ASCITES1 reports
ASPARTATE AMINOTRANSFERASE INCREASED1 reports
ASTHENIA1 reports
BENIGN PROSTATIC HYPERPLASIA1 reports
BILIARY DILATATION1 reports
BLOOD LACTATE DEHYDROGENASE INCREASED1 reports
BLOOD POTASSIUM DECREASED1 reports
BLOOD PRESSURE DECREASED1 reports
BLOOD THYROID STIMULATING HORMONE INCREASED1 reports
BLOOD UREA INCREASED1 reports
BRAIN ABSCESS1 reports
CARDIAC ARREST1 reports
CARDIAC DISORDER1 reports
CARDIO RESPIRATORY ARREST1 reports
CARDIOMYOPATHY1 reports
CHRONIC KIDNEY DISEASE1 reports
CLOSTRIDIUM DIFFICILE COLITIS1 reports
CONDITION AGGRAVATED1 reports
CONTUSION1 reports
CONVULSION1 reports
CYSTITIS1 reports
CYSTITIS HAEMORRHAGIC1 reports
DEHYDRATION1 reports
DENTAL CARIES1 reports
DEPRESSION1 reports
DERMATITIS ACNEIFORM1 reports
DRUG RESISTANCE1 reports
DRY SKIN1 reports
DUODENAL ULCER1 reports
DYSGEUSIA1 reports
DYSLIPIDAEMIA1 reports
DYSPNOEA EXERTIONAL1 reports
EJECTION FRACTION DECREASED1 reports

Report Outcomes

Out of 52 classified reports for WHITE PETROLEUM:

Serious 94.2%Non-Serious 5.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male29 (56.9%)
Female22 (43.1%)

Reports by Age

Age 603 reports
Age 362 reports
Age 452 reports
Age 492 reports
Age 512 reports
Age 632 reports
Age 742 reports
Age 772 reports
Age 31 reports
Age 71 reports
Age 191 reports
Age 251 reports
Age 301 reports
Age 321 reports
Age 381 reports
Age 471 reports
Age 551 reports
Age 591 reports
Age 611 reports
Age 641 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with WHITE PETROLEUM?

This profile reflects 195 FDA FAERS reports that mention WHITE PETROLEUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for WHITE PETROLEUM?

Frequently reported terms in FAERS include PYREXIA, PNEUMONIA, PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME, RENAL FAILURE, HYPERTENSION, BLOOD CREATININE INCREASED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures WHITE PETROLEUM?

Labeling and FAERS entries often list Home Smart Products in connection with WHITE PETROLEUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.